In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
about
An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Protein-Protein Interactions between Hepatitis C Virus Nonstructural ProteinsAdenovector-mediated hair cell regeneration is affected by promoter type.A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse earsRecent advances in genetic modification of adenovirus vectors for cancer treatmentImplication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsEffects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNSGene delivery with viral vectors for cerebrovascular diseases.Aberrant dynamin 2-dependent Na(+) /H(+) exchanger-1 trafficking contributes to cardiomyocyte apoptosis.Gene therapy: design and prospects for craniofacial regeneration.Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity.The promise and potential hazards of adenovirus gene therapy.Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response.Optimization of the helper-dependent adenovirus system for production and potency in vivo.Current status of gene therapy for inherited lung diseasesEpisomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivoSuppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayersRegulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.Conditionally replicating adenoviruses for cancer treatment.NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.Progress and problems when considering gene therapy for GSD-II.Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block.Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses.Helper-Dependent Adenoviral Vectors.Viral hybrid vectors for somatic integration - are they the better solution?Adenoviral producer cellsGene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes.Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subsetRole for the adenovirus IVa2 protein in packaging of viral DNADevelopment and characterization of novel empty adenovirus capsids and their impact on cellular gene expression.Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses.Gene transfer into canine myoblasts.
P2860
Q27469506-761C3E17-E28E-4947-A7BD-7E2254D2B911Q27472916-3C4B6875-4BE7-4947-9BF2-0AF7FB5C43FAQ27473469-EC542AD4-9AC3-4BED-8B99-E0ED9F3A1C3CQ30364969-89A339E8-9DAD-4343-B99B-C56B65ED96D1Q33640285-6CFDD67F-2E19-41A3-AAEB-0682A31AC07BQ33738828-B4DD90C7-3882-452A-825C-FA305026FEBAQ33813779-7A032A8D-C32C-4D9F-8BC1-3359ADA59085Q33815920-F39DDFDF-0DE3-4F5B-92B7-B5DAE71A99C8Q33817535-7763BA13-0642-4AD7-94EA-32DEB889B595Q33818929-97A7188A-BFFE-4F87-BFC8-CB42B9398EA0Q33819873-E5D3A81E-309E-4897-82CB-CAB909D30F0AQ33894621-C7AF3C41-CA7D-4858-A81A-16446128FE9EQ33917592-2EE168BC-7A01-4632-A989-23519DA78631Q33985612-57A5F585-175A-4430-8496-BA804476EE4AQ34007347-99675FDA-1F26-48EA-AC4D-51847D56F98BQ34201134-0FCE02A3-FD84-4921-B0D2-51FD87546008Q34219407-F9AEA7BF-154E-49B7-849F-7D91D846EE52Q34327129-9C8E874A-08F0-4309-9DF2-3CB924C1C5CAQ34996749-40CBE15A-D740-4711-90D6-662A87A72FF9Q35043830-87F1200D-DBA8-49F8-ACDB-BC5F6A0C9A2BQ35149966-653FBF0F-E2B7-4BF6-8EA8-59A737CDFAA6Q35184207-B8E62A39-BD85-4D3E-96C7-A15E72D27751Q35810067-535C5E32-A86B-4971-B7BB-A9F271142B15Q35842184-9C8D38F1-3AB7-4FEF-B5BA-9F631FA26EFAQ35967313-E4D7F6F0-8A20-48D4-831C-9E556245BA07Q36507633-621A5870-A4F8-405D-A42D-0560111339F3Q36960374-E71B904A-6035-4DEF-9D74-68E0D7CFB0DFQ37105417-3D316391-845A-4FD1-A7C4-A4CB240DF547Q37378133-D052D2E7-FC6C-49A5-B2AD-217106AB0046Q37582126-33D5211A-FBAB-4830-ACC9-3584A7E3FAF9Q37945189-8E2A5A4A-7A25-4F81-8896-0F59A4CE38DCQ37945217-2F4B0D25-5020-41C3-BDD7-641B708B0181Q37945218-0678D877-2A9D-4726-8C46-05A5D6D656C8Q39549150-8A20FE31-149A-4B43-8CE3-2B8023900AAFQ39592823-6969D735-51E4-4A9F-8470-C93C0D740BECQ39597114-5391BD78-58B5-449D-A111-66152223183FQ39604759-6B82492D-43A5-4CEC-9BD3-F25D1D9BCF4AQ40173334-4396526B-BA89-42B2-9BE1-A782734DD182Q40175603-BA6178B0-A898-491A-B61C-57675ECF04ABQ41789265-A8E2BAA7-734A-47EE-BD66-35B13DC203CA
P2860
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@ast
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@en
type
label
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@ast
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@en
prefLabel
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@ast
In vitro and in vivo biology o ...... E1, E1/E2A, or E1/E4 deleted.
@en
P2093
P2860
P1433
P1476
In vitro and in vivo biology o ...... h E1, E1/E2A, or E1/E4 deleted
@en
P2093
A Dieterle
A Pavirani
F Stoeckel
P2860
P304
P577
1998-03-01T00:00:00Z